A Preliminary Analysis of Inferior Vena Cava Filters with and without Anticoagulation vs Anticoagulation Only: Readmission and Mortality Rates.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 1776-1776 ◽  
Author(s):  
Henny Heisler Billett ◽  
Noah Kornblum ◽  
Laurie Jacobs ◽  
Nicholas Gargiulo

Abstract Inferior vena cava (IVC) filters are an increasingly popular option for patients with thrombosis and the advent of temporary filters may make this procedure an even more desirable alternative. We decided to evaluate how patients with inferior vena cava filters fared when compared to patients without such filters. A new software program, Clinical Looking Glass, replicates hospital records for statistical access with or without identifiers as defined by IRB-approved protocols. A cohort of patients who had a discharge diagnosis of deep venous thrombosis (DVT) and who had had an IVC filter insertion from 10/1/97 until 5/19/04 was defined. Within this group, a subgroup who had a filter and who had anticoagulation (AC) with an INR between 1.5 and 10 within 3650 days after filter were defined (F-AC) and within this group, a further subgroup whose INR values were between 1.5 and 10 within one year of filter insertion were defined. (F-AC 1YR). Those patients with filters but without any elevations in their INR were classified as ‘Filter - No AC’. The comparison groups were patients without filters who were discharged with a diagnosis of DVT and whose INR values were between 1.5 and 10 within the first year (DVT-AC 1YR). All patients were analyzed for their readmission rates for any diagnosis, for readmission for DVT, and for mortality. 749 patients were classified as DVT- AC 1YR, 533 patients as Filter - No AC, 103 patients as F-AC, and 63 patients as F-AC 1YR. Patients with inferior vena cava filters and anticoagulation were readmitted with the diagnosis of DVT significantly more often than patients without inferior vena cava filters (p<0.0003, RR 1.75 (95%CI 1.51, 2.03), and the mortality tended to be higher at 1 yr (p=.051). In comparison, the group with filter and no anticoagulation had a lower rate of readmission (23.3%, p vs. filter AC p<1x10−8, p vs. DVT AC 1 Yr <0.0003). DVT-AC 1 Yr F-AC 1 YR Filter - No AC Total 749 63 533 Readmissin Rate (n,%) 261 (34.8%) 35 (56%) 124 (23.3%) Days to Readmission 276.8 190 455.3 Mortality at 1 yr 12% 18% Mortality at 5 yr 15% 38% Median Age (yrs) 64 66 75 Readmission for any Dx (n,%) 496 (66.2%) 55 (87.3%) 309 (60.0%) DVT Incidence Density 0.51 0.90 0.21 When 5-year mortality was analyzed for those patients with an IVC filter who were not anticoagulated (Filter -No AC) vs. those who were (F-AC 1YR), there was a very significant difference in favor of anticoagulation but when these were age adjusted (initial median age difference 75yr vs. 66 yrs respectively), no differences were noted. There was no significant gender difference in readmissions for filter patients with or without anticoagulation. For patients with anticoagulation only, a mild gender difference in readmission rate was demonstrated (female: male 41%: 32%, n=785, p<0.04). Although this study suggests that filters with AC do not give added benefit over simple AC to patients, these preliminary analyses have not been performed incorporating severity of illness, indication for filter placement, comorbidities, time in therapeutic AC range or duration of anticoagulation. These retrospective analyses are forthcoming but these preliminary data suggest that a controlled prospective study which examines the efficacy of inferior vena cava filters with and without anticoagulation is necessary to determine its role in antithrombotic therapy.

Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 5592-5592
Author(s):  
Rachel Hensel ◽  
Saurabh Rohatgi ◽  
Imre Bodó

Abstract Background: Technical improvements of inferior vena cava filters (IVCF) have led to a markedly increased use of this modality over the last two decades.While these devices may provide significant short-term protection from pulmonary embolism (PE) in patients for whom anticoagulation is contraindicated or ineffective, the risk-benefit ratio is unknown in a variety of indications not recommended by current guidelines. Serious long-term complications include an increased risk of deep vein thrombosis (DVT), IVCF malposition, fracture, migration and embolism. Methods: In this paper, we describe a case demonstrating multiple complications of IVCF placement. In addition, we attempted to review all available literature to identify data on the risk-benefit ratio of conventional versus liberal use of IVCF. Results: (i) Case Description: A 38-year-old woman with a history of recurrent VTE presented with severe abdominal pain. Her initial left popliteal vein thrombosis and PE had occurred in 2000 after a few months on oral contraceptives (OC). She was treated with warfarin for a year. A recurrent unprovoked episode of left iliofemoral DVT was diagnosed four years later, at which time she was off OC. Indefinite warfarin treatment was started, given her young age and recurrent VTE. She became pregnant two years later and was switched to enoxaparin until two months after delivery. However, she did not restart warfarin and experienced no complications until three years later, when a prophylactic temporary IVC filter was placed prior to partial hysterectomy for menorrhagia. The surgery was performed without complications, but six months later she developed a recurrent untriggered right femoral DVT and began to experience sharp pains and an abrupt change in her bowel habits. At presentation, a CT scan (below) determined that her IVC filter had migrated out of position with its wires protruding into her aorta and spine and perforating her duodenum. Major abdominal and vascular surgery was performed to remove the filter. A thrombophilia panel returned with normal results. The patient was started on rivaroxaban indefinitely with no further issues. (ii) Literature review: A PubMed search of all English language clinical trials with the key word "IVC filter" resulted in a total of 46 papers, 6 of which did not focus on outcomes of cava filters leaving 40 papers for review. These 40 papers were individually studied. We could identify no papers directly comparing standard versus liberal indications. Complication rates varied widely among the reviewed case series. Conclusion: While temporary IVC filters are an effective method of preventing PE when anticoagulation therapy is contraindicated or ineffective, there is no data in current medical literature comparing outcomes of standard versus liberal indications of IVCF use. Such studies are urgently needed to support or refute current medical practices in the United States and other developed countries. Furthermore, retrievable filters should be retrieved as soon as clinically feasible to avoid long-term complications, such as illustrated by our case. Axial contrast-enhanced CT showing migrated anterior arm of IVC filter protruding into the duodenum. Sagittal CT image showing posterior arm extending to the adjacent psoas muscle. Figure 1. Figure 1. Figure 2. Figure 2. Disclosures No relevant conflicts of interest to declare.


2019 ◽  
Vol 213 (4) ◽  
pp. 768-777 ◽  
Author(s):  
Ronald S. Winokur ◽  
Noy Bassik ◽  
David C. Madoff ◽  
David Trost

TH Open ◽  
2021 ◽  
Vol 05 (01) ◽  
pp. e73-e80
Author(s):  
Filip Ionescu ◽  
Nwabundo Anusim ◽  
Eva Ma ◽  
Lihua Qu ◽  
LeAnn M. Blankenship ◽  
...  

AbstractRecognition of the adverse events of inferior vena cava filters (VCFs) has prompted the Food and Drug Administration (FDA) to issue safety warnings (2010 and 2014), advocating for removal, once the risk of pulmonary embolism has abated. Despite an initial increase in retrieval rates, these remain low (25–30% at 1 year in 2014). We retrospectively investigated retrieval trends in adults with VCFs placed between 2015 and 2018 at a single institution. The rate of retrievable VCF removal accounting for the competing risk of death was the main outcome. There were 494 VCFs placed (305 retrievable). The cumulative incidence of retrieval remained low (21% at 1 year), even after the second FDA warning (2014). Patients who resumed anticoagulation (AC) at any time were more likely to have retrieval (hazard ratio [HR] = 3.6, p < 0.01) and had higher retrieval rates at every time point (31.4 vs. 7.6% at 1 year). Advanced age (HR = 0.98 per year, p = 0.004), stroke (HR = 0.28, p = 0.028), and active malignancy (HR = 0.42, p = 0.006) predicted nonretrieval. Device-related complications were infrequent (<1%) but thrombotic complications occurred early and were more common for nonretrieved VCFs (17 vs. 12%, p = 0.29). Revision of guidelines to recommend active surveillance for the ability to tolerate AC in the immediate postimplantation period may improve retrieval rates.


Author(s):  
Anil Pillai ◽  
Manoj Kathuria ◽  
Maria del Pilar Bayona Molano ◽  
Patrick Sutphin ◽  
Sanjeeva P Kalva

2021 ◽  
pp. 026835552092598
Author(s):  
Jacob J Bundy ◽  
Jeffrey Forris Beecham Chick ◽  
Ravi N Srinivasa ◽  
Kyle J Cooper ◽  
Joseph J Gemmete ◽  
...  

Objective The Simon Nitinol filter is a bi-level filtration device designed for permanent implantation that is no longer commercially available, but may result in similar complications to current commercially available long term indwelling temporary or permanent filters. Complications related to indwelling inferior vena cava filters include inferior vena cava thrombosis, inferior vena cava penetration, filter migration, and filter fracture. There is a paucity of reports describing the technical aspects related to retrieval of Simon Nitinol filters. Materials and methods This study consisted of five patients with Simon Nitinol filters and describes the indication for retrieval, the retrieval techniques used to remove the filters, technical success, complications, and clinical course. Results The indications for retrieval included: abdominal pain ( n = 2; 40%), iliocaval thrombosis ( n = 1; 20%), identification of an intracardiac filter fragment ( n = 1; 20%), and recurrent venous thromboembolic events ( n = 1; 20%). Retrieval techniques included: biopsy forceps ( n = 3; 60%), excimer laser extraction sheaths ( n = 3; 60%), hangman modified loop snares ( n = 3; 60%), rigid endobronchial forceps ( n = 2; 40%), and balloon deflection ( n = 2; 40%). All filters were successfully retrieved. One patient developed a post-procedural intramuscular hematoma near the site of right internal jugular sheath placement. Conclusions Simon Nitinol filters may be retrieved safely and effectively using advanced inferior vena cava filter retrieval techniques.


2017 ◽  
Vol 38 (01) ◽  
pp. 084-093 ◽  
Author(s):  
Jonathan Steinberger ◽  
Anshuman Bansal ◽  
John Moriarty

2012 ◽  
Vol 55 (6) ◽  
pp. 60S
Author(s):  
Elsie Gyang ◽  
Mohamed Zayed ◽  
E. John Harris ◽  
Jason T. Lee ◽  
Ronald L. Dalman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document